comparemela.com
  1. Home
  2. Live Updates
  3. Third Under Examination - Breaking News

Latest Breaking News On - Third under examination - Page 1 : comparemela.com

Propanc Biopharma, Inc : Propanc Biopharma Receives Notice of Allowance for Proenzyme Compositions to Treat Cancer from the European Patent Office

The Second Patent Application Allowed with a Third Under Examination in Europe Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company developing novel cancer

Kostenloser wertpapierhandelJames nathanielszExchange commissionTrademark officeEuropean patent officePropanc biopharma incCompany mechanism of actionSecond patent application allowedThird under examinationChief executivePropanc biopharma

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.